Predictive factors of hospital stay in patients undergoing minimally invasive transforaminal lumbar interbody fusion and instrumentation

Spine
Krzysztof SiemionowKern Singh

Abstract

A single-center retrospective study. To identify predictors of length of stay (LOS) days in patients undergoing 1 level minimally invasive (MIS) transforaminal lumbar interbody fusions (TLIF). Recent studies suggest intraoperative fluid administration, and colloid and crystalloid administration among other intraoperative variables may prolong LOS days and increase complications. Therefore, an understanding of which preoperative, intraoperative, and immediate postoperative parameters best predict immediate LOS days will help risk stratify patients and guide decision making. We retrospectively reviewed 104 patients undergoing a MIS TLIF at 1 institution between 2008 and 2010. Two groups were selected on the basis of the time of discharge. Group 1 consisted of patients discharged within 24 hours after surgery and group 2 consisted of patients discharged more than 24 hours after surgery. Multiple regression analysis was performed to determine which preoperative, intraoperative, and postoperative variables were independent predictors of LOS days. Seventy-eight patients (75%) with a LOS greater than 24 hours had significantly higher estimated blood loss, received more crystalloids, had higher total fluids, longer surgical time, lower...Continue Reading

References

Sep 1, 1987·The Journal of Trauma·G J JurkovichP W Curreri
Jun 1, 1994·Spine·D C CherkinG Waddell
Apr 1, 1993·British Journal of Anaesthesia·A SharkeyA H Giesecke
Jun 10, 2000·Science·C J Woolf, M W Salter
Feb 13, 2002·Spine·Bernard H GuiotRichard G Fessler
May 6, 2004·The Spine Journal : Official Journal of the North American Spine Society·C SekarYogesh K Pithwa
Sep 11, 2007·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·G T McArdleD W Harkin
Nov 22, 2008·International Orthopaedics·Constantin SchizasVictor Kosmopoulos
Apr 8, 2010·JAMA : the Journal of the American Medical Association·Richard A DeyoJeffrey G Jarvik
Apr 23, 2010·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Jian WangJie Liu
Jul 27, 2010·Surgical Neurology International·Alan T VillavicencioAlexander Mason

❮ Previous
Next ❯

Citations

Dec 3, 2014·The Spine Journal : Official Journal of the North American Spine Society·Saddam F KanaanNeena K Sharma
Nov 5, 2013·The Spine Journal : Official Journal of the North American Spine Society·Jordan A GruskayJonathan N Grauer
May 28, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Rafael De la Garza-RamosDaniel M Sciubba
Feb 15, 2019·Clinical Spine Surgery : a Spine Publication·Kangwu ChenHaiqing Mao
Jul 12, 2018·Neurospine·Benjamin C MayoKern Singh
Jul 29, 2019·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Ellen M SoffinJames D Beckman
Aug 23, 2019·Global Spine Journal·Kazuyoshi KobayashiShiro Imagama
Feb 6, 2020·HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery·Ellen M SoffinJiabin Liu
Aug 28, 2020·Frontiers in Surgery·Corinna OngaiguiSergio D Bergese
Jul 16, 2019·Current Reviews in Musculoskeletal Medicine·Hannah WeissNader S Dahdaleh
Aug 31, 2018·Neurosurgery·Ahilan SivaganesanAnthony L Asher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.